Atascadero, CA, United States of America

Thomas A Kirkland

This inventor holds 61 USPTO granted patents and 17 published patent applications, plus 3 CIPO patents and 23 EPO patents, primarily in Bioluminescence Technology (CPC class G01N). Top assignees: Promega Corporation, Celtaxsys, Inc., Celltaxis, LLC. Active years: 2010-2026.

USPTO Granted Patents = 61 (Patent Applications = 17)

% Patents Active = 98.4

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 23 (Patent Applications = 41)

Average Co-Inventor Count = 6.5

ph-index = 7

Forward Citations = 177(Granted Patents)

Forward Citations (Not Self Cited) = 91(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Atascadero, CA (US) (2010 - 2024)
Madison, WI (US) (2020 - 2024)

Company Filing History:

Estrellita Pharmaceuticals, LLC

patent

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Bioluminescence

Luciferase Enzymes

Thermostable Luciferins

Covalent Tethering

Cell-Permeable Linkers

Imidazo[1,2-a]pyrazines

Coelenterazine Analogues

Thermal Shift Assays

Bioactive Agents

Inhibitors

Photoaffinity Probes

Reversible Metal Ion Chelators

61 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12655398 - MULTIPARTITE LUCIFERASE (2026-06-16),

2. 12571031 - Nucleic acid modifying reagents and uses thereof (2026-03-10),

3. 12545899 - LUCIFERASE ENZYMES FOR USE WITH THERMOSTABLE LUCIFERINS IN BIOLUMINESCENT ASSAYS (2026-02-10),

4. 12391973 - Substituted imidazo[1,2-α]pyrazines as luciferase substrates (2025-08-19),

5. 12367513 - Activation of bioluminescence by structural complementation (2025-07-22),

6. 12366572 - Activation of bioluminescence by structural complementation (2025-07-22),

7. 12221648 - Substrates for covalent tethering of proteins to functional groups or solid surfaces (2025-02-11),

8. 12173009 - Diamine derivatives as inhibitors of leukotriene Ahydrolase (2024-12-24),

9. 11913944 - Photoaffinity probes (2024-02-27),

10. 11899021 - Luciferase-based thermal shift assays (2024-02-13),

11. 11781168 - Process for preparing substituted imidazo[1,2-α]pyrazines (2023-10-10),

12. 11767517 - Luciferase enzymes for use with thermostable luciferins in bioluminescent assays (2023-09-26),

13. 11740249 - Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer (2023-08-29),

14. 11691976 - Coelenterazine analogues (2023-07-04),

15. 11667648 - Cell-permeable, cell-compatible, and cleavable linkers for covalent tethering of functional elements (2023-06-06),

Certainly! Here is the article about inventor Thomas A Kirkland:

Title: The Innovative Mind of Thomas A Kirkland

Introduction:

Thomas A Kirkland, a prolific inventor based in Atascadero, CA (US), has made significant contributions to the field of molecular research and target engagement. With an impressive portfolio of 53 patents, Kirkland's work has been instrumental in advancing scientific knowledge and technology.

Latest Patents:

Among Kirkland's latest patents are two groundbreaking innovations:

1. Photoaffinity probes: These probes enable precise labeling of molecular targets through specific interactions and covalent linking via a photoreactive group.

2. Luciferase-based thermal shift assays: Kirkland's invention facilitates the characterization of target/ligand engagement using luciferase-labeled polypeptide targets.

Career Highlights:

Throughout his career, Thomas A Kirkland has worked with top companies in the industry, including Promega Corporation and Celtaxsys, Inc. His expertise and dedication have led to the development of cutting-edge technologies that have reshaped the way researchers approach molecular studies.

Collaborations:

Kirkland has collaborated with esteemed professionals in the field, such as Keith V Wood and Mary P Hall. Their synergistic efforts have resulted in groundbreaking advancements and have paved the way for future innovations in molecular research.

Conclusion:

In conclusion, Thomas A Kirkland stands out as a visionary inventor whose work continues to inspire and drive progress in the realm of molecular biology. His dedication to excellence and commitment to innovation exemplify the essence of a true pioneer in the field.